Download FREE Sample
Hospital-acquired Infections (HAIs), also known as healthcare-associated infections, are infections that are acquired during or after receiving treatment in healthcare settings such as hospitals, specialty clinics, ASCs, and long-term care facilities. These infections are not present or incubating at the time of admission and typically occur due to exposure to infectious pathogens within the healthcare facilities. These pathogens (bacteria, viruses, fungi) spread via contaminated surfaces, medical devices, or inadequate hand hygiene by staff. Some common types include bloodstream infections, surgical site infections, ventilator-associated pneumonia, urinary tract infections linked to catheter use, and infections caused by multidrug-resistant organisms. HAIs can lead to higher mortality, increased morbidity, longer hospital stays, and significant financial burden on healthcare systems. Healthcare providers are incorporating different products, technologies, and services to prevent, diagnose, monitor, and manage these infections. These include sterilization and disinfection equipment, antimicrobial coatings, infection surveillance software, diagnostic tools, personal protective equipment, and antimicrobial therapies, among others
Increasing hospitalization, surgical volumes, and infection prevention priorities supporting market expansion
The surge in the number of hospital-acquired infections (HAIs) remains a significant concern for global healthcare systems. According to the World Health Organization (WHO), approximately 1 in 10 patients worldwide acquires an HAI during care at a healthcare facility. This rise in the number of HAIs is primarily driven by the increase in hospital admissions and surgical procedures, which has further led to the corresponding need for infection prevention and control solutions. Moreover, the growing burden of chronic diseases, the rising elderly population, and the increasing number of trauma and emergency cases have not only increased the number of invasive medical procedures including catheterization, implantation, and mechanical ventilation, but also has created potential entry points for pathogens thereby increasing the likelihood of infections, particularly among patients with weak immune systems or those require long-term care or in ICUs.
Further, the overall rise in surgical volumes has elevated the importance of maintaining sterile environments and ensuring the proper sterilization of medical instruments and healthcare facilities. According to the World Health Organization (WHO), more than 300 million surgical procedures are performed each year. These interventional procedures require strict sterilization protocols to prevent infection transmission through instruments or direct patient contact. In addition, growing awareness regarding hygiene and infection prevention within healthcare settings has reinforced the adoption of standardized infection control protocols. Healthcare providers are placing greater emphasis on infection prevention due to the clinical and financial impact associated with extended hospital stays, additional treatments, and increased resource utilization. Regulatory bodies and healthcare institutions are also enforcing stricter sterilization and infection prevention guidelines to improve patient safety and reduce infection-related complications. This has resulted in sustained demand for infection prevention products and technologies across acute care and specialty care environments.
To learn more about this report, download the PDF brochure
Increasing prevalence of antimicrobial-resistant (AMR) pathogens to drive HAI market
The rising prevalence of antimicrobial-resistant (AMR) pathogens has emerged as a critical healthcare concern, threatening global public health as a silent pandemic, necessitating urgent interventions. This increase in the number of AMR organisms is one of the key factors driving the hospital-acquired infection (HAI) market, not only transforming treatment protocols but also accelerating the demand for novel and higher-cost therapies and has further led to growing investments in strengthening infection prevention and control infrastructure, services, and monitoring systems within healthcare facilities.
Hospitals and healthcare facilities are increasingly encountering multidrug-resistant organisms including pathogens, such as Enterococcus Faecium,Staphylococcus Aureus,Klebsiellm>,Acinetobacter Baumannii,Pseudomonas AeruginosaandEnterobacterSpecies, which pose a high risk of infection, particularly for vulnerable patients in ICUs, surgical wards, and long-term care facilities. This has resulted in increasing of HAIs, leading to prolonged hospital stays, higher treatment costs, and increased mortality risk. The increasing focus on infection control is a primary factor driving the adoption of infection prevention technologies, as healthcare providers prioritize reducing infection risks, improving patient safety, and enhancing clinical outcomes.
Additionally, antimicrobial-resistant infections are prompting hospitals to strengthen sterilization protocols, im"https://meditechinsights.com/surface-disinfectant-market/" target="_blank" rel="noopener">disinfection technologies, and expand surveillance programs to prevent pathogen transmission. This growing emphasis on infection control has accelerated demand for the automated sterilization workflows and increased frequency of environmental decontamination procedures, particularly in high-risk healthcare environments.
Furthermore, healthcare systems are increasing investments in preventive strategies, including automated sterilization systems, antimicrobial coatings, and environmental hygiene solutions, to reduce the burden of resistant infections and improve overall infection control efficiency. These measures are essential not only for maintaining operational efficiency to reduce infection-related complications but also for preventing outbreaks and supporting healthcare providers to maintain higher standards of clinical safety and quality assurance.
Adoption of automated and digital infection surveillance systems
Traditional manual surveillance methods are labour-intensive and prone to delays, whereas digital systems have enabled real-time monitoring of infection patterns. This facilitates the adoption of automated infection surveillance platforms by healthcare providers to improve infection detection and prevention. This shift towards digital systems, mainly driven by advancements in electronic health records (EHR) and artificial intelligence (AI), is further reshaping how hospitals detect, report, and prevent healthcare-associated infections.
These systems integrate patient data, laboratory results, and clinical records to identify infection patterns, such as an increase in central-line-associated bloodstream infections (CLABSI) or surgical site infections (SSI), as they happen rather than weeks later. This automated screening process has enabled infection control teams to respond quickly to emerging outbreaks.
The integration of artificial intelligence and predictive analytics is further enhancing surveillance capabilities by providing real-time dashboards, allowing teams to act immediately to isolate patients, change cleaning protocols, or adjust antibiotic stewardship, thereby reducing the overall rate of infections. These automated systems not only enhance infection detection and prevention but also automate the creation of reports for mandatory, federal, or state submissions, thereby enhancing the completeness of data and ensuring compliance with regulations. Overall, these advancements are improving infection control efficiency and contributing to increased adoption of digital monitoring solutions across healthcare settings.
To learn more about this report, download the PDF brochure
Type Segment Outlook
The global hospital acquired infection market by type is categorized into equipment (sterilization and disinfection equipment), services and consumables (disinfectants and sterilization consumables). The consumables segment holds the largest share of the market, due to the growing adoption of single-use, disposable products to prevent cross-contamination, particularly in ICUs and surgical theatres. Followed by consumables, the equipment segment holds a significant share of the market. This segment growth is driven by rising surgical procedures globally, stringent guidelines from government bodies requiring regular sterilization and decontamination, particularly in hospitals and ASCs. The service segment is projected to expand rapidly due to the rise in demand for contract sterilization services and advanced infection controlmonitoring software & solutions by hospitals tnfection rates.
Regional Outlook: North America is expected to hold a major share in the hospital acquired infection market
North America holds the largest share in the hospital acquired infection market, followed by Europe and Asia Pacific. The large share of North America can be attributed to the rising prevalence of hospital-acquired infections, due to better adoption of sterilization technologies, high healthcare expenditure, and stringent regulations & guidelines imposed by the government in the region. Europe represents the second-largest market, followed by North America, with a high prevalence of HAI, significant investments in infection prevention and control solutions, stringent European Medicines Agency (EMA) regulations, rising awareness of patient safety, and high-quality healthcare standards. However, APAC is expected to witness strong growth in the coming years due to a large patient population, the rising number of surgeries, rapid expansion of private hospital infrastructure, and increased government initiatives for infection control.
Competitive Landscape Analysis
The global hospital acquired infection market is marked by the presence of established and emerging market players such as 3M Company (US); Belimed Inc. (Switzerland); O&M Halyards (US); Getinge AB (Sweden); ASP (Advanced Sterilization Products Services, Inc.) (US); Sterigenics U.S., LLC (A Sotera Health Company) (US); MMM Group (Germany); Midmark Corporation (US); STERIS plc (US); and W&H (Austria) among others. Some of the key strategies adopted by market players include product innovation and development, strategic partnerships and collaborations, mergers and acquisitions, and geographic expansion.
Get a sample report for competitive landscape analysis
Report Scope
| Report Metric | Details |
| Base Year Considered | 2025 |
| Historical Data | 2024 2025 |
| 2026 2031 | |
| 6% | |
| Segment Scope | Type and End User |
| Regional Scope |
|
| Market Drivers |
|
| Attractive Opportunities |
|
| Key Companies Mapped | 3M Company (US); Belimed Inc. (Switzerland); O&M Halyards (US); Getinge AB (Sweden); ASP (Advanced Sterilization Products Services, Inc.) (US); Sterigenics U.S., LLC (A Sotera Health Company) (US); MMM Group (Germany); Midmark Corporation (US); STERIS plc (US); and W&H (Austria); among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Hospital Acquired Infection Market Segmentation
This report by Medi-Tech Insights provides thesize of the global hospital acquired infection market at theregional- and country-level from 2024 to 2031. The report further segments the market based on source, type, application, and end-user.
Market Size & Forecast (2024-2031), By Type, USD Billion
- Equipment
- Sterilization Equipment
- Heat Sterilization Equipment
- Low Temperature Sterilization
- Radiation Sterilization
- Disinfection Equipment
- Washer Disinfector
- Flusher Disinfector
- Endoscopic Reprocessor Systems
- Services
- Consumables
- Disinfectants
- Sterilization Consumables
Market Size &-2031), By End-user, USD Billion
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Ambulatory Surgical Centers (ASCs)
- Others
Market Size & Forecast (2024-2031), By Region, USD Billion
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Related Reports:
Frequently Asked Questions About This Report
What is the growth rate of the hospital acquired infection market?
The hospital acquired infection market is set to witness a growth rate of 6% during the forecast period from 2026 to 2031
What is the current and forecasted market size of the global hospital acquired infection market?
The global hospital acquired infection market size is valued at $XX billion in 2025 and is projected to reach $XX billion in 2031
What are the key trends defining the market?
Increasing adoption of automated disinfection systems and integration of AI-based infection monitoring tools are major trends in the hospital acquired infection market
What are the major factors impacting the market growth?
The market growth is supported by increasing hospitalization rates, rising surgical procedure volumes, and growing antimicrobial resistance. In addition, regulatory bodies are enforcing stricter infection control standards, compelling healthcare providers to adopt advanced sterilization systems, diagnostic solutions, and infection surveillance platforms, which are some of the key factors driving the hospital acquired infection market
Who are the major players operating in the market?
Some of the major players operating in the hospital acquired infection market include 3M Company (US); Belimed Inc. (Switzerland); O&M Halyards (US); Getinge AB (Sweden); ASP (Advanced Sterilization Products Services, Inc.) (US); Sterigenics U.S., LLC (A Sotera Health Company) (US); MMM Group (Germany); Midmark Corporation (US); STERIS plc (US); and W&H (Austria) among others
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.
